ArticleWorld journal of gastroenterology2019
Short- and long-term outcomes of endoscopically treated superficial non-ampullary duodenal epithelial tumors.
Article in World journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.
- Evaluation of endoscopic submucosal dissection as a treatment option for duodenal tumors ≥ 20 mm: a systematic review and meta-analysis by lesion size.Journal of gastroenterology · 2026Pooled it
- Clinical practice guidelines for duodenal cancer 2021.Journal of gastroenterology · 2022Guideline
- Endoscopic Resection for Non‑ampullary Duodenal Lesions: 13 Years of Experience from a Large Tertiary Center in China.Digestive diseases and sciences · 2026Observational
- Clinical practice guidelines for duodenal cancer 2025.Journal of gastroenterology · 2026Review
- Safety and Feasibility of Laparoscopic and Endoscopic Cooperative Surgery With Endoscopic Submucosal Dissection for Large Superficial Non-Ampullary Duodenal Epithelial Tumors.Annals of gastroenterological surgery · 2026Article
- Prophylactic mucosal defect closure reduces delayed adverse events after endoscopic resection of large-to-giant laterally spreading superficial non-ampullary duodenal epithelial tumors.Surgical endoscopy · 2026Article
- Endoscopic Resection for Superficial Non-Ampullary Duodenal Epithelial Tumors.Gut and liver · 2025Review
- Jejunal Enterotomy for Specimen Retrieval in D-LECS: A Case Report.Surgical case reports · 2025Article
- Case Report: A rare case of a giant sporadic non-ampullary duodenal adenoma that was safely and effectively resected using hybrid endoscopic submucosal dissection.Frontiers in oncology · 2025Article
- The incidence of nonampullary duodenal cancer in Japan 2016-2020: analysis of a national cancer registry.Journal of gastroenterology and hepatology · 2024Article
- A first-in-human clinical study of laparoscopic autologous myoblast sheet transplantation to prevent delayed perforation after duodenal endoscopic mucosal dissection.Stem cell research & therapy · 2024Article
- Endoscopic diagnosis and treatment of superficial non-ampullary duodenal epithelial tumors: A review.Journal of translational internal medicine · 2023Article
- Endoscopic resection of non-ampullary duodenal adenomas: Is cold snaring the promised land?World journal of gastrointestinal endoscopy · 2023Review
- Article
- Clinical Outcome of Resected Non-Ampullary Duodenal Adenocarcinoma: A Single Center Experience.Journal of clinical medicine · 2022Article
- Current endoscopic diagnosis treatment strategy for superficial nonampullary duodenal tumours.European journal of medical research · 2022Review
- Review
- Rapid and chronological expression of angiogenetic genes is a major mechanism involved in cell sheet transplantation in a rat gastric ulcer model.Regenerative therapy · 2022Article
- Survival comparison between endoscopic and surgical resection for non-ampullary duodenal neuroendocrine tumor (1-2 cm).Scientific reports · 2022Article
- Outcomes of endoscopic mucosal resection for large superficial non-ampullary duodenal adenomas.Scientific reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIt is widely recognized that endoscopic resection (ER) of superficial non-ampullary duodenal epithelial tumors (SNADETs) is technically challenging and may carry high risks of intraoperative and delayed bleeding and perforation. These adverse events could be more critical than those occurring in other levels of the gastrointestinal tract. Because of the low prevalence of the disease and the high risks of severe adverse events, the curability including short- and long-term outcomes have not been standardized yet.
aimTo investigate the curability including short- and long-term outcomes of ER for SNADETs in a large case series.
methodsThis retrospective study included cases that underwent ER for SNADETs at our university hospital between March 2004 and July 2017. Short-term outcomes of ER were measured based on
resultsIn the study, 131 patients with 147 SNADETs were analyzed. The 147 ERs consisted of 136 endoscopic mucosal resections (EMRs) (93%) and 11 endoscopic submucosal dissections (ESDs) (7%). The median tumor diameter was 10 mm. The pathology diagnosis was adenocarcinoma (56/147, 38%), high-grade intraepithelial neoplasia (44/147, 30%), or low-grade intraepithelial neoplasia (47/147, 32%). The R0 resection rate was 68% (93/136) in the EMR group and 73% (8/11) in the ESD group, respectively. Cap-assisted EMR (known as EMR-C) showed a higher rate of R0 resection compared to the conventional method of EMR using a snare (78%
conclusionOur findings suggest that ER provides good long-term outcomes in the patients with SNADETs. EMR is likely to become the safe and reliable treatment for small SNADETs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.